Treatment of essential thrombocythemia in patients younger than 60 years who have no symptoms and an acceptable platelet count is usually watchful waiting.
Treatment of other patients may include the following:
- Anagrelide therapy
- Biologic therapy using interferon alfa
- Platelet apheresis (therapeutic removal of platelets from the blood)
- A clinical trial of a new investigational treatment